Home Articles List Article Information
Suez Canal Veterinary Medical Journal. SCVMJ
Journal Archive
Volume Volume 29 (2024)
Volume Volume 28 (2023)
Volume Volume 27 (2022)
Volume Volume 26 (2021)
Volume Volume 25 (2020)
Volume Volume 24 (2019)
Volume Volume 23 (2018)
Volume Volume 22 (2017)
Volume Volume 21 (2016)
Volume Volume 20 (2015)
Volume Volume 19 (2014)
Volume Volume 18 (2013)
merzek, J. (2023). Ameliorating Effects of chrysanthemum against Anti Cancer Drug capecitabine in Albino Rats. Suez Canal Veterinary Medical Journal. SCVMJ, (), -. doi: 10.21608/scvmj.2023.202880.1124
jaklin lotfy merzek. "Ameliorating Effects of chrysanthemum against Anti Cancer Drug capecitabine in Albino Rats". Suez Canal Veterinary Medical Journal. SCVMJ, , , 2023, -. doi: 10.21608/scvmj.2023.202880.1124
merzek, J. (2023). 'Ameliorating Effects of chrysanthemum against Anti Cancer Drug capecitabine in Albino Rats', Suez Canal Veterinary Medical Journal. SCVMJ, (), pp. -. doi: 10.21608/scvmj.2023.202880.1124
merzek, J. Ameliorating Effects of chrysanthemum against Anti Cancer Drug capecitabine in Albino Rats. Suez Canal Veterinary Medical Journal. SCVMJ, 2023; (): -. doi: 10.21608/scvmj.2023.202880.1124

Ameliorating Effects of chrysanthemum against Anti Cancer Drug capecitabine in Albino Rats

Articles in Press, Accepted Manuscript, Available Online from 05 June 2023  XML
Document Type: Original Article
DOI: 10.21608/scvmj.2023.202880.1124
View on SCiNiTO View on SCiNiTO
Author
jaklin lotfy merzek email
department of forensic medicine and toxicology faculty of veterinary medicine Suez Canal University
Abstract
The present study was undertaken to evaluate the impact of Chrysanthemum on some hematological parameters in the anticancer drug capecitabine (xeloda) exposed male rats . Thirty six albino rat were divided into 6 groups (6 animals each) as follows:1) capecitabine (xeloda at dose of 30 mg as apositive control); 2) capecitabine (xeloda) + low dose of Chrysanthemum (5 mg); 3) capecitabine (xeloda) + high dose of Chrysanthemum (10 mg) ); 4) Chrysanthemum (low dose, 5 mg) 5) Chrysanthemum ( high dose, 10 mg); 6) Control group (negative control) for 45 days. The results of the present study revealed that capecitabine (xeloda) treatment induce decrease in RBCS, leukocytes, and platelets count, level of HBG and HCT, however the treatment with capecitabine (xeloda) in combination with Chrysanthemum ameliorate these changes especially with the high dose of Chrysanthemum. In conclusion, the data suggest that the complimentary use of Chrysanthemum with capecitabine (xeloda) treatment will be beneficial to reduce the adverse effect of capecitabine (xeloda) in chemotherapy.
Keywords
Chrysanthemum; hematological parameters; capecitabine
Main Subjects
Forensic Medicine and Toxicology
Statistics
Article View: 62